Tempus AI (NASDAQ:TEM) Earns Neutral Rating from Analysts at Piper Sandler

Piper Sandler assumed coverage on shares of Tempus AI (NASDAQ:TEM) in a report published on Monday, Marketbeat reports. The firm issued a neutral rating and a $40.00 target price on the stock.

Several other brokerages also recently issued reports on TEM. Needham & Company LLC reiterated a buy rating and issued a $47.00 price target on shares of Tempus AI in a report on Wednesday, August 7th. William Blair began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an outperform rating for the company. Morgan Stanley began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an overweight rating and a $44.00 price objective for the company. TD Cowen began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a buy rating and a $50.00 price objective for the company. Finally, Stifel Nicolaus began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a buy rating and a $45.00 price objective for the company. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of Moderate Buy and an average price target of $45.56.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $42.90 on Monday. Tempus AI has a 12-month low of $22.89 and a 12-month high of $47.09. The firm has a fifty day moving average of $36.72.

Hedge Funds Weigh In On Tempus AI

Several large investors have recently modified their holdings of TEM. Sandia Investment Management LP bought a new position in Tempus AI in the second quarter worth about $136,000. Northwestern University bought a new position in Tempus AI in the second quarter worth about $491,000. Squarepoint Ops LLC bought a new position in Tempus AI in the second quarter worth about $633,000. WINTON GROUP Ltd bought a new position in Tempus AI in the second quarter worth about $634,000. Finally, EFG Asset Management North America Corp. bought a new position in Tempus AI in the second quarter worth about $1,333,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.